Biological Sample Collection Kits Market Report 2026

Biological Sample Collection Kits Market Overview

• Biological Sample Collection Kits market size has reached to $11.39 billion in 2025 • Expected to grow to $19.26 billion in 2030 at a compound annual growth rate (CAGR) of 10.8% • Growth Driver: Growth of Biological Sample Collection Kits Market Driven By Rise In Infectious Diseases • Market Trend: Innovation In Biological Sample Collection Kits Enhanced Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biological Sample Collection Kits Market?

Biological sample collection kits are tools designed for the safe and efficient collection, storage, and transportation of biological specimens such as blood, saliva, urine, or tissue. These kits typically include sterile containers, swabs, and preservatives to maintain the integrity of the samples for diagnostic or research purposes. The main types of biological sample collection kits are swabs, viral transport media, blood collection kits, and others. Swabs are tools used for collecting samples from various body sites for medical testing, often involving a soft tip attached to a stick. The applications include diagnostics, and research, utilized by various end users such as hospitals and clinics, home test, diagnostics centers, and others.

What Is The Biological Sample Collection Kits Market Growth Forecast?

The biological sample collection kits market size is expected to see rapid growth in the next few years. It will grow to $19.26 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising demand for homecare and self-collection test kits, growing use of dna and rna collection kits in genomics applications, higher utilization of blood and saliva kits in chronic disease and screening programs, expansion of research biobanking and longitudinal cohort studies, increasing preference for user-friendly and transport-stable collection formats. Major trends in the forecast period include increasing use of biological sample collection kits in diagnostic testing, growing adoption of at-home and remote sample collection solutions, rising utilization of swabs, vtm, and blood collection kits in clinical settings, expansion of sample collection for research and biobanking applications, focus on sterility, safety, and sample integrity during transportation and storage.

Global Biological Sample Collection Kits Market Segmentation

1) By Product: Swabs, Viral Transport Media, Blood Collection Kits 2) By Application: Diagnostics, Research 3) By End-Use: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End-Uses Subsegments: 1) By Swabs: Nasopharyngeal Swabs, Oropharyngeal Swabs, Flocked Swabs, Polyester Swabs 2) By Viral Transport Media (VTM): Liquid VTM, Dry VTM 3) By Blood Collection Kits: Venous Blood Collection Kits, Capillary Blood Collection Kits, Fingerstick Blood Collection Kits

What Is The Driver Of The Biological Sample Collection Kits Market?

The rise in the number of infectious diseases is expected to propel the growth of the biological sample collection kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted from person to person. Infectious diseases are on the rise due to factors such as increased global travel, urbanization, antimicrobial resistance, environmental changes, and inadequate healthcare infrastructure. Biological sample collection kits are crucial in infectious disease management, enabling the safe and efficient collection of specimens for diagnosis, monitoring, and research purposes. For instance, in March 2024, according to Centers for Disease Control and Prevention, a US-based national public health agency, reported a 16% rise in U.S. tuberculosis cases from 2022 to 2023, with a total of 9,615 cases and an incidence rate increase from 2.5 to 2.9 per 100,000 people. Significant increases were noted in Hispanic (23%) and Black (28%) groups among non-U.S.-born individuals, underscoring the demographic shifts in TB incidence. Therefore, the rise in the number of infectious diseases is driving the growth of the biological sample collection kits industry.

Key Players In The Global Biological Sample Collection Kits Market

Major companies operating in the biological sample collection kits market are Thermo Fisher Scientific Inc, Roche Holding AG, Abbott Laboratories, Becton Dickinson and Company, 3M Company, Copan Diagnostics Inc, Puritan Medical Products Inc, HiMedia Laboratories Pvt Ltd, Omega Laboratories Ltd, VIRCELL SL, Titan Biotech Ltd, BTNX Inc, MWE Medical Wire and Equipment Co Ltd, Quidel Corporation, Greiner Bio‑One International GmbH, Terumo Corporation, Sarstedt AG & Co KG, QIAGEN NV, Deltalab Spain, Trinity Biotech Ltd

Global Biological Sample Collection Kits Market Trends and Insights

Major companies operating in the biological sample collection kits market are developing innovative products, such as personalized diagnostic test kits, to better serve customers with advanced features. Personalized diagnostic test kits are tools designed to detect specific biomarkers or genetic information tailored to an individual's unique health profile for a customized medical diagnosis. For instance, in March 2023, Cue Health, a US-based diagnostic test service provider, launched at-home diagnostic test kits. This at-home test kit includes all the necessary supplies for safe, easy, and private sample collection. Once the sample is sent to and processed by an independent, CLIA-certified laboratory, clear and understandable results are securely delivered to the customer through the Cue Health App, along with information about their condition or concern.

What Are Latest Mergers And Acquisitions In The Biological Sample Collection Kits Market?

In March 2024, Halma plc, a UK‑based group of life‑saving technology companies, acquired Rovers Medical Devices B.V., a Netherlands‑based manufacturer of sample collection devices (including brushes for cervical cell sampling), for $92.6 million. With this acquisition, Halma aimed to strengthen its women’s‑health and diagnostics business by integrating Rovers’ established cervical‑cancer sample‑collection technology into its portfolio. Rovers Medical Devices is a Netherlands‑based provider of sample collection devices used in the prevention and diagnosis of cervical cancer.

Regional Outlook

North America was the largest region in the biological sample collection kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Biological Sample Collection Kits Market?

The biological sample collection kits market consists of sales of blood collection tubes, saliva collection devices, urine collection containers, swabs for microbial sampling, and tissue biopsy kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.